Amedeo Smart

Free Medical Literature Service

 

Amedeo

Osteoporosis
  Free Subscription

Articles published in
Osteoporos Int
    September 2025
  1. HAN X, Xia M
    Letter to the editor concerning "Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study".
    Osteoporos Int. 2025 Sep 22. doi: 10.1007/s00198-025-07678.
    >> Share

  2. FALK SSI, Mittlmeier T
    Should we consider ankle fractures as osteoporotic fractures?
    Osteoporos Int. 2025 Sep 19. doi: 10.1007/s00198-025-07690.
    >> Share

  3. ORHADJE E, Berg K, Whitehead K, Hauser B, et al
    Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis.
    Osteoporos Int. 2025 Sep 12. doi: 10.1007/s00198-025-07618.
    >> Share

  4. MONTOYA-GARCIA MJ, Carbonell-Abella C, Garcia MG, Hernandez-Cruz B, et al
    Adequacy of pharmacological prescription in patients at very high risk of fracture within the FLS in Spain: analysis of the REFRA FLS-SEIOMM Registry.
    Osteoporos Int. 2025 Sep 12. doi: 10.1007/s00198-025-07565.
    >> Share

  5. BOBELYAK M, Vaculik J, Stepan JJ
    Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement.
    Osteoporos Int. 2025 Sep 10. doi: 10.1007/s00198-025-07685.
    >> Share

  6. LO SW, Yen HK, Huang CC, Lu YC, et al
    Incidence, risk factors, prognosis of periprosthetic fractures post hip fracture: unveiling protective role of anti-osteoporotic medication.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07670.
    >> Share

  7. ZHANG X, Xu D, Zhang R, Wang H, et al
    Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07636.
    >> Share

  8. LIU Y, Arora T, Zhang J, Sen B, et al
    Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07677.
    >> Share

  9. CLARK P, Calo M, Bostico ST, de Pedro AO, et al
    Latin American patients' perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07684.
    >> Share

  10. CRUZ-PRIEGO GA, Araiza-Nava B, Mendez-Sanchez L, Vargas-Chanes D, et al
    Predictive capacity of fracture risk assessment tools: overview of systematic reviews.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07642.
    >> Share

  11. KONSTANTELOS N, Kim S, Cheung AM, Burden AM, et al
    The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose.
    Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07672.
    >> Share

  12. TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
    Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD) - emulation of a randomized target trial.
    Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07687.
    >> Share

  13. XIAO YJ, Zhou YY, Liu YQ
    Zoledronic acid-induced acute psychiatric disorder.
    Osteoporos Int. 2025;36:1767-1769.
    >> Share

  14. KABRA A, Katzman WB, Lane NE, Giangregorio LM, et al
    OsteoStrong and bone health: a scoping review.
    Osteoporos Int. 2025;36:1521-1534.
    >> Share

  15. LEE JH, Heo SJ, Kim KM, Lee JE, et al
    Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab.
    Osteoporos Int. 2025;36:1661-1669.
    >> Share

  16. PRASAD TN, Flora SS, Bhadada SK, Yadav U, et al
    Anti-resorptive and anabolic therapies improve Falls Risk Assessment Score (FRAS) in postmenopausal women with type 2 diabetes mellitus.
    Osteoporos Int. 2025;36:1633-1639.
    >> Share

  17. LIN J, Tjokrosaputro PP, Ang BH, Chew CK, et al
    Prolonged hypercalcemia induced by teriparatide: a case report and literature review.
    Osteoporos Int. 2025;36:1763-1766.
    >> Share

  18. BILLINGS E, Dash AS, Raphael J, Heilbronner AK, et al
    Skeletal risk factors for postoperative complications in older men undergoing spinal fusion surgery.
    Osteoporos Int. 2025;36:1547-1555.
    >> Share

    August 2025
  19. GUTIERREZ-HERMOSILLO H, de Leon-Gonzalez ED
    Advantages of measuring hand grip strength in osteoporosis patients.
    Osteoporos Int. 2025 Aug 29. doi: 10.1007/s00198-025-07680.
    >> Share

  20. DE FORD C, Guridi M, Chen Y, Murphy AP, et al
    Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review.
    Osteoporos Int. 2025 Aug 29. doi: 10.1007/s00198-025-07651.
    >> Share

  21. HIREDESAI AN, Holle AM, Payne CS, Beckett NC, et al
    Assessing endocrinology referral rates and osteoporosis directed-care after upper extremity fragility fractures.
    Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07665.
    >> Share

  22. ZENG ZJ, PengPeng, Huang CL, Yao FM, et al
    More severe microdamage and micromechanical alterations: altered subchondral bone remodeling in varus knee osteoarthritis with osteoporosis.
    Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07652.
    >> Share

  23. NGUYEN HG, Nguyen DT, Tran TS, Ling SH, et al
    Artificial intelligence system for predicting areal bone mineral density from plain X-rays.
    Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07634.
    >> Share

  24. MCCLOSKEY EV, Johansson H, Liu E, Akesson KE, et al
    Family history of fracture and fracture risk: a meta-analysis to update the FRAX(R) risk assessment tool.
    Osteoporos Int. 2025 Aug 23. doi: 10.1007/s00198-025-07607.
    >> Share

  25. JIN H, Jin H, Suk KS, Lee BH, et al
    Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07661.
    >> Share

  26. KO Y, Song BG, Shin H, Park Y, et al
    Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07649.
    >> Share

  27. HARVEY NC, Al-Daghri N, Beaudart C, Brandi ML, et al
    Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07628.
    >> Share

  28. LI CC, Ou LC, Chang YF, Chang CS, et al
    Performance and interventional cutoffs of osteoporosis self-assessment tools in the community: implications for screening and early referral.
    Osteoporos Int. 2025 Aug 20. doi: 10.1007/s00198-025-07656.
    >> Share

  29. DU X, Nouraie SM, Pu J, Karoleski C, et al
    Lung-related risk factors associate with low bone mineral density in individuals with former tobacco exposure not meeting osteoporosis screening criteria.
    Osteoporos Int. 2025 Aug 19. doi: 10.1007/s00198-025-07648.
    >> Share

  30. SCHOTT EM, Charbonneau MR, Kiel DP, Bukata S, et al
    A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women.
    Osteoporos Int. 2025 Aug 15. doi: 10.1007/s00198-025-07650.
    >> Share

  31. SIAMPANOPOULOU V, Ziogas DC, Lyrarakis G, Anastasopoulou A, et al
    Bone mineral density changes following immune checkpoint inhibitor therapy: insights from a case series analysis.
    Osteoporos Int. 2025 Aug 10. doi: 10.1007/s00198-025-07647.
    >> Share

  32. CHUNG H, Kim TY, Kim J, Ha YC, et al
    Long-term trends of osteoporotic hip fractures in South Korea: analysis of National Health Insurance Data from 2006 to 2022.
    Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07537.
    >> Share

  33. BORSATI A, Adamoli G, Giannarelli D, Belluomini L, et al
    Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07645.
    >> Share

  34. GU Y, Wang Y, Li M, Wang R, et al
    Current applications of deep learning in vertebral fracture diagnosis.
    Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07604.
    >> Share

  35. CASSINAT J, Wright V
    A cost-saving analysis of pharmacologic management in osteoporotic fracture prevention among postmenopausal women.
    Osteoporos Int. 2025 Aug 1. doi: 10.1007/s00198-025-07621.
    >> Share

  36. PELEPENKO LE, de Oliveira MC, Masaro DA, Lustosa GMMM, et al
    Effects of microplastics on the bones: a comprehensive review.
    Osteoporos Int. 2025;36:1327-1345.
    >> Share

  37. CHEN J, Cao L, Xu C, Lu F, et al
    Modified criteria for identifying elevated bone mass.
    Osteoporos Int. 2025;36:1433-1445.
    >> Share

    July 2025
  38. CHUAN F, Mei M, Liao K, Ye X, et al
    DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients.
    Osteoporos Int. 2025 Jul 30. doi: 10.1007/s00198-025-07644.
    >> Share

  39. WANG X, Ji C, Li S, Wang K, et al
    Quantitative computed tomography provides improved accuracy for diagnosis of lumbar osteoporosis in patients with facet joint osteoarthritis: a cross-sectional study.
    Osteoporos Int. 2025 Jul 27. doi: 10.1007/s00198-025-07600.
    >> Share

  40. NIAZI S, Mazloomi M, Ostovar A, Fahimfar N, et al
    Fatty acid dietary intakes and blood concentrations in relation to hip fracture risk in adults: a systematic review and meta-analysis of prospective cohort studies.
    Osteoporos Int. 2025 Jul 27. doi: 10.1007/s00198-025-07587.
    >> Share

  41. CHUN MY, Jeon J, Chung SJ, Kim J, et al
    Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study.
    Osteoporos Int. 2025 Jul 24. doi: 10.1007/s00198-025-07611.
    >> Share

  42. LYU FF, Zhang M, Deng YF, Liu Q, et al
    Incidence and predictors of residual back pain after percutaneous vertebral augmentation in osteoporotic vertebral compression fracture: a systematic review and meta analysis.
    Osteoporos Int. 2025 Jul 23. doi: 10.1007/s00198-025-07609.
    >> Share

  43. LIU L, Li D
    Letter to the editor concerning "The impact of a fracture liaison service with in?hospital anti?osteoporosis treatment on subsequent hip fracture and mortality rates-a single?center retrospective study".
    Osteoporos Int. 2025 Jul 17. doi: 10.1007/s00198-025-07433.
    >> Share

  44. GU HY, Liu N, Lin FX, Yin J, et al
    Nrf2 signaling pathway: focus on oxidative stress in osteoporosis.
    Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07592.
    >> Share

  45. KNIGHT T, Eley S
    Postmenopausal osteoporosis continuing education needed for healthcare professionals? A quality improvement project.
    Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07571.
    >> Share

  46. LUO Z, Feng A, Tyurin A, Cui Q, et al
    Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses.
    Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07620.
    >> Share

  47. LLOPIS-CARDONA F, Rodriguez-Bernal CL, Hurtado I, Espallargues M, et al
    Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain.
    Osteoporos Int. 2025 Jul 12. doi: 10.1007/s00198-025-07564.
    >> Share

  48. O'HARE B, Santaguida P, Azizudin AM, Papaioannou A, et al
    The role of physical performance measures in the physiotherapy assessment and management of older adults with osteoporotic vertebral fractures: a narrative review.
    Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07606.
    >> Share

  49. ZOULAKIS M, Johansson H, Harvey NC, Axelsson KF, et al
    Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study.
    Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07588.
    >> Share

  50. KO Y, Song BG, Shin H, Park Y, et al
    Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
    Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07602.
    >> Share

  51. XIA L, Chi H, Cao Q
    Letter to the editor about "the impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study".
    Osteoporos Int. 2025 Jul 7. doi: 10.1007/s00198-025-07432.
    >> Share

  52. HARISH S, Moon RJ, Harvey NC, Inskip HM, et al
    Maternal smoking before and during pregnancy and offspring bone mineral density in early childhood: findings from the Southampton Women's Survey.
    Osteoporos Int. 2025 Jul 2. doi: 10.1007/s00198-025-07581.
    >> Share

  53. MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al
    No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial.
    Osteoporos Int. 2025;36:1231-1237.
    >> Share

  54. FERRARI S, Akesson KE, Al-Daghri N, Biver E, et al
    Bone microstructure and TBS in diabetes: what have we learned? A narrative review.
    Osteoporos Int. 2025;36:1115-1128.
    >> Share

    June 2025
  55. PARK J, Kim JW, Nam JH, Kim Y, et al
    Comparative analysis of osteoporotic versus pathologic fracture in metastatic colorectal cancer patients.
    Osteoporos Int. 2025 Jun 30. doi: 10.1007/s00198-025-07575.
    >> Share

  56. DEMERS AJ, Fitton LS, McCulley SML, Delgado-Arellanes I, et al
    Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up.
    Osteoporos Int. 2025 Jun 27. doi: 10.1007/s00198-025-07557.
    >> Share

  57. ZHAO AY, Chiu A, Agarwal AR, Harris AB, et al
    The growing burden of periprosthetic fractures after total hip arthroplasty: identifying overall trends and at-risk groups.
    Osteoporos Int. 2025 Jun 26. doi: 10.1007/s00198-025-07583.
    >> Share

  58. MCLAUGHLIN EC, Giangregorio LM, Adachi JD, Laing AC, et al
    Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2025 Jun 25. doi: 10.1007/s00198-025-07435.
    >> Share

  59. KAMIYA K, Kojima A, Tachiki T, Imai N, et al
    Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07577.
    >> Share

  60. WANG H, Zhao Y, Liu Q, Jiang Z, et al
    Global burden of low bone mineral density related fractures in pre- and post-menopausal women from 1990 to 2021, with projections to 2050.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07586.
    >> Share

  61. MOON RJ, D'Angelo S, Curtis EM, Ward KA, et al
    Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07568.
    >> Share

  62. DING Q, Zhou B, Leung J, Kwok T, et al
    Global trends in burden of fractures, low bone mineral density, and high body mass index from 1990 to 2021, an age-period-cohort analysis.
    Osteoporos Int. 2025 Jun 17. doi: 10.1007/s00198-025-07570.
    >> Share

  63. SHOGRY FF, Hayes KN, Kim S, Burden AM, et al
    The rise and fall of raloxifene use for osteoporosis, 1999-2022.
    Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07544.
    >> Share

  64. MARSELOU E, Kelekis A, Dimitriadis Z, Koumantakis GA, et al
    Risk factors for refracture or new vertebral compression fractures after percutaneous vertebroplasty: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07523.
    >> Share

  65. SON HJ, Park SJ, Park JS, Han K, et al
    Impact of smoking, diabetes, and exercise on dementia risk in women with osteoporosis: a nationwide cohort study.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07524.
    >> Share

  66. TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
    Authors' response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-024-07293.
    >> Share

  67. CHEN J, Zhou Q, Yu W, Cao D, et al
    Renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07534.
    >> Share

  68. ZHANG Y, Ma M, Huang X, Liu J, et al
    Machine learning is changing osteoporosis detection: an integrative review.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07541.
    >> Share

  69. BUGBIRD AR, Matheson BE, Walle M, Neeteson NJ, et al
    Quantifying localized bone loss in clinical computed tomography using void spaces.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07558.
    >> Share

  70. CIROVIC A, Milovanovic P
    Can adjustment for iron, zinc, and calcium levels clarify the relationship between blood cadmium and bone mineral density?
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07434.
    >> Share

  71. HUANG CF, Ho CJ, Lin SY, Hwang JS, et al
    Asia-Pacific consensus for the management of osteoporosis in men.
    Osteoporos Int. 2025 Jun 4. doi: 10.1007/s00198-025-07559.
    >> Share

  72. SHARAFI MH, Nazari A, Cheraghi M, Souri F, et al
    The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches.
    Osteoporos Int. 2025 Jun 2. doi: 10.1007/s00198-025-07553.
    >> Share

  73. BISCHOFF-FERRARI HA, Dawson-Hughes B, Orav JE, Ceglia L, et al
    Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial.
    Osteoporos Int. 2025;36:1007-1018.
    >> Share

    May 2025
  74. RIPPL M, Grupp P, Martini S, Muller K, et al
    Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk.
    Osteoporos Int. 2025 May 30. doi: 10.1007/s00198-025-07540.
    >> Share

  75. CHENG R, Zhang L
    Case report on possible causes of severe osteoporosis: diffuse panbronchiolitis.
    Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07532.
    >> Share

  76. MASHARAWI Y, Lerner A, Weisman A
    Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures.
    Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07526.
    >> Share

  77. BERNATZ JT, Sandhu KP, Krueger D, Borchardt G, et al
    Trabecular bone score predicts distal femur screw pull-out strength better than DXA bone mineral density, CT Hounsfield units, and cortical density.
    Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07530.
    >> Share

  78. LI H, Wang H
    Association between weekend warrior physical activity pattern and bone mineral density among adults: national health and nutrition examination survey.
    Osteoporos Int. 2025 May 26. doi: 10.1007/s00198-025-07535.
    >> Share

  79. GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
    Author response to: among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2025 May 23. doi: 10.1007/s00198-025-07520.
    >> Share

  80. MONEGAL A, Carrasco JL, Peris P, Frade-Sosa B, et al
    Results of the implementation of a multidisciplinary care protocol for preventing fragility fractures following liver transplantation.
    Osteoporos Int. 2025 May 22. doi: 10.1007/s00198-025-07525.
    >> Share

  81. UM YJ, Cho IY, Koo HY, Park YM, et al
    Intellectual disabilities and risk of fractures: A population-based cohort study.
    Osteoporos Int. 2025 May 13. doi: 10.1007/s00198-025-07519.
    >> Share

  82. PRAVEEN AD, Jha D, Baker A, Fleps I, et al
    Comparison of the time-dependent discriminatory accuracy of femoral strength and bone mineral density for predicting future hip and major osteoporotic fractures: a 16-year follow-up of the AGES-Reykjavik cohort.
    Osteoporos Int. 2025 May 12. doi: 10.1007/s00198-025-07503.
    >> Share

  83. ORAVEC D, Yadav RN, Cushman T, Flynn MJ, et al
    Osteoporosis screening in the mammography setting via digital wrist tomosynthesis.
    Osteoporos Int. 2025 May 9. doi: 10.1007/s00198-025-07516.
    >> Share

  84. LIU E, Liu RY, Moraros J, McCloskey EV, et al
    Association between walking and hip fracture in women aged 65 and older: 20-year follow-up from the study of osteoporotic fractures.
    Osteoporos Int. 2025 May 7. doi: 10.1007/s00198-025-07508.
    >> Share

  85. WU Q, Jung J
    Precision fracture risk assessment: leveraging genomic and clinical data for personalized care.
    Osteoporos Int. 2025 May 6. doi: 10.1007/s00198-025-07517.
    >> Share

  86. OUYANG W, Guo G, Zhao C
    Comment on: The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
    Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07430.
    >> Share

    April 2025
  87. HOUEL V, Marchasson G, Ramdane N, Philippoteaux C, et al
    Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis.
    Osteoporos Int. 2025 Apr 29. doi: 10.1007/s00198-025-07486.
    >> Share

  88. ALBRECHT AP, Kistler-Fischbacher M, De Godoi Rezende Costa Molino C, Armbrecht G, et al
    Prevalence and incidence of osteoporotic vertebral fractures in community-dwelling European older adults: an observational analysis of the DO-HEALTH trial.
    Osteoporos Int. 2025 Apr 25. doi: 10.1007/s00198-025-07489.
    >> Share

  89. ADAMS H, Salman L, Drinkwater KJ, Griffin J, et al
    Improved radiological diagnosis of osteoporotic vertebral fragility fractures following UK-wide interventions and re-audit-can this be maintained and translated into clinical practice?
    Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07488.
    >> Share

  90. PIGNOLO RJ, Connell JJ, Briggs W, Kelly CJ, et al
    Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight: validation of an AI-based tool in a US population.
    Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07487.
    >> Share

  91. GORGEY AS, Venigalla S, Deitrich JN, Ballance WB, et al
    Electrical stimulation paradigms on muscle quality and bone mineral density after spinal cord injury.
    Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07482.
    >> Share

  92. IFTIKHAR QUA
    Bridging the gap: validating AI for real-world osteoporosis screening.
    Osteoporos Int. 2025 Apr 15. doi: 10.1007/s00198-025-07496.
    >> Share

  93. ORHADJE E, Makaram N, Berg K, Hauser B, et al
    Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07479.
    >> Share

  94. LO HZ, Leow K, Hii R, Nerlekar N, et al
    Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07468.
    >> Share

  95. LI J, Fu X, Shi H, Jing J, et al
    Protective role of irisin on bone in osteoporosis: a systematic review of rodent studies.
    Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07470.
    >> Share

  96. BAUMANN AN, Krez AN, Trager RJ, Anaspure OS, et al
    Osteoporosis is not associated with increased reoperation or fracture risk three years after total ankle arthroplasty: a retrospective cohort study.
    Osteoporos Int. 2025 Apr 4. doi: 10.1007/s00198-025-07473.
    >> Share

  97. HAYES KN, Zullo AR, Berry SD, Oganisian A, et al
    Osteoporosis medication use over time in the United States and Canada.
    Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07484.
    >> Share

  98. LIU L, Wang Y, Tan B, Huang P, et al
    Association of beta-adrenergic receptor blockers use with the risk of fracture in adults: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07471.
    >> Share

  99. GATINEAU G, Hind K, Shevroja E, Gonzalez-Rodriguez E, et al
    Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0 with direct correction for soft tissue thickness-the osteolaus study.
    Osteoporos Int. 2025;36:715-724.
    >> Share

  100. KHAN AA, AbuAlrob H, Ali DS, Al Kassem Z, et al
    Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR).
    Osteoporos Int. 2025;36:673-684.
    >> Share

  101. VARENNA M, Zucchi F, Di Taranto R, Orsini F, et al
    Osteoclast in CRPS: an alleged guilty fully acquitted.
    Osteoporos Int. 2025;36:737-740.
    >> Share

  102. PATINO-SALAZAR JD, Ovejero D, Gabernet M, Martinez-Gil N, et al
    Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women.
    Osteoporos Int. 2025;36:637-644.
    >> Share

  103. WOLF JVE, Schoene D, Kohl M, Kemmler W, et al
    Effects of combined protein and exercise interventions on bone health in middle-aged and older adults - A systematic literature review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2025;36:609-625.
    >> Share

    March 2025
  104. BHATTOA HP, Vasikaran S, Trifonidi I, Kapoula G, et al
    Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Internatio
    Osteoporos Int. 2025 Mar 28. doi: 10.1007/s00198-025-07422.
    >> Share

  105. PAN Y, Wan Y, Wang Y, Yu T, et al
    Conventional chest computed tomography-based radiomics for predicting the risk of thoracolumbar osteoporotic vertebral fractures.
    Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-024-07338.
    >> Share

  106. MARKARIAN AM, Taaffe DR, Bettariga F, Luo H, et al
    Bone mineral density in childhood cancer survivors during and after oncological treatment: A systematic review and meta-analysis.
    Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-025-07458.
    >> Share

  107. BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
    Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
    Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07452.
    >> Share

  108. SOPINA L, Hitz MF, Thygesen LC, Langdahl B, et al
    Healthcare and productivity cost of osteoporosis: a Danish register-based quasi-experimental study.
    Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07453.
    >> Share

  109. GERDHEM P, Wihlborg A, Bergstrom IB
    Site-specific volumetric skeletal changes in women with and without a distal forearm fracture: a case-control study with a mean 7-year follow-up.
    Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07412.
    >> Share

  110. SHAHZAD UB, Hanif U, Aiman U
    From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies.
    Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07457.
    >> Share

  111. YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al
    Author response to letter to the editor, (OSIN-D-25-00227) "From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies".
    Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07466.
    >> Share

  112. PARK JH, Kwon O, Choi JH, Yeom JS, et al
    Perioperative teriparatide for preventing proximal junctional kyphosis and failure in patients with osteoporosis after adult thoracolumbar spinal deformity surgery: a prospective randomized controlled trial.
    Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07449.
    >> Share

  113. STARUP-LINDE J, Stoy J, Grinderslev PB, Langdahl B, et al
    Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an observational study.
    Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07443.
    >> Share

  114. GHASEMINEJAD-RAEINI A, Hoveidaei AH, Zarepour F, Taghavi SP, et al
    Notable lacking of bone mineral density measurement in cushing syndrome: a nationwide study based on the US insurance claim database.
    Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07418.
    >> Share

  115. PARK JW, Kim HY, Kim KM, Kim J, et al
    Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006-2022).
    Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07429.
    >> Share

  116. BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
    PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
    Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07440.
    >> Share

  117. ZHANG Q, Gao W, Xu X, Cui R, et al
    Elevated baseline CTX levels predict enhanced therapeutic efficacy of zoledronic acid in augmenting lumbar spine bone mineral density among Chinese osteoporosis patients.
    Osteoporos Int. 2025 Mar 4. doi: 10.1007/s00198-025-07448.
    >> Share

  118. ENRIQUE LR, Francisco TN, Inigo EF, Cristina OT, et al
    Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM.
    Osteoporos Int. 2025;36:375-389.
    >> Share

  119. ZHOU K, Zhu Y, Luo X, Yang S, et al
    A novel hybrid deep learning framework based on biplanar X-ray radiography images for bone density prediction and classification.
    Osteoporos Int. 2025;36:521-530.
    >> Share

  120. LAURSEN N, Solling AS, Harslof T, Langdahl B, et al
    Clinical experience with denosumab discontinuation.
    Osteoporos Int. 2025;36:435-446.
    >> Share

    February 2025
  121. PETERSEN TG, Rubin KH, Javaid MK, Hermann AP, et al
    Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE.
    Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07436.
    >> Share

  122. LIU J, Zhang Y, Yu W, Sun L, et al
    TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.
    Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07423.
    >> Share

  123. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
    Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.
    Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-025-07397.
    >> Share

  124. ONTAN MS, Isik AT
    Author response to: OSIN-D-24-01894 comment on "Osteoporosis in older patients with idiopathic normal pressure hydrocephalus".
    Osteoporos Int. 2025 Feb 12. doi: 10.1007/s00198-025-07387.
    >> Share

  125. MO S, Gu Y
    Comment on "Osteoporosis in older patients with idiopathic normal pressure hydrocephalus".
    Osteoporos Int. 2025 Feb 11. doi: 10.1007/s00198-025-07416.
    >> Share

  126. CHEN R, Gong K, Chen W, Chen Z, et al
    Author response to: OSIN-D-24-01898: Comment on "Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018".
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07388.
    >> Share

  127. SHAO J, Zhang H, Fei Q
    Comment on "Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018".
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07417.
    >> Share

  128. LO JC, Chandra M, Khan MM, Barzilay J, et al
    Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system.
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-024-07372.
    >> Share

  129. MAKKAR B, Obremskey W, Avidano R, Ott S, et al
    The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs).
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07401.
    >> Share

  130. NAKAJIMA K, Horii C, Kodama H, Shirokoshi T, et al
    Association between vertebral fractures and brain volume: insights from a community cohort study.
    Osteoporos Int. 2025 Feb 5. doi: 10.1007/s00198-025-07403.
    >> Share

  131. TICINESI A, Siniscalchi C, Meschi T, Nouvenne A, et al
    Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies.
    Osteoporos Int. 2025;36:167-191.
    >> Share

  132. BINKLEY N, Sempos CT, Borchardt G, Larsen J, et al
    Association of standardized serum 25-hydroxyvitamin D with falls in post-menopausal women.
    Osteoporos Int. 2025;36:255-264.
    >> Share

    January 2025
  133. NOOR A, Nabi R, Khan HT, Noor A, et al
    Bridging the gap: enhancing osteoporosis management through AI-driven predictive models.
    Osteoporos Int. 2025 Jan 29. doi: 10.1007/s00198-025-07396.
    >> Share

  134. KAWAMURA K, Murata S, Kitano Y, Mera Y, et al
    Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment.
    Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07404.
    >> Share

  135. NASO CM, Lin SY, Song G, Xue H, et al
    Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005-2018.
    Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07395.
    >> Share

  136. BROOKS ELG, Tangney CC, Ritz EM
    Ultra-processed food intake and prevalence of osteoporosis in US adults aged 50 years and older: a cross-sectional analysis.
    Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07394.
    >> Share

  137. PATRA S
    Response to the letter "OSIN-24-D-01312, letter to the editor commenting on 'evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case-control study from India'".
    Osteoporos Int. 2025 Jan 23. doi: 10.1007/s00198-024-07354.
    >> Share

  138. YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al
    Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case-control study.
    Osteoporos Int. 2025 Jan 16. doi: 10.1007/s00198-025-07386.
    >> Share

  139. LI X, Cheng L
    The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions.
    Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07389.
    >> Share

  140. DURBIN JW, Zhao AY, Cui E, Agarwal AR, et al
    Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020.
    Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07385.
    >> Share

  141. LIU Z, Tian M, Duan L
    Enhancing emergency management for osteoporotic patients: a commentary on physical activity and mortality insights.
    Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07371.
    >> Share

  142. LEE S, Hong N, Cho SJ, Shin S, et al
    Effect of romosozumab on bone mineral density and trabecular bone score in premenopausal women with low bone mass.
    Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07336.
    >> Share

  143. ANDREASEN C, Dahl C, Frihagen F, Borgen TT, et al
    Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative).
    Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376.
    >> Share

  144. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-025-07383.
    >> Share

  145. HUANG Z, Liao TC, Chuang AT, Shao SC, et al
    Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07381.
    >> Share

  146. CAO D, Cao Z, Liu A
    Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07374.
    >> Share

  147. CHEN F, Luo J, Li L
    The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12-19 years.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07349.
    >> Share

  148. BUGBIRD AR, Boisvert NMJ, Burt LA, Boyd SK, et al
    Choose your mother wisely: the familial resemblance of bone adaptation.
    Osteoporos Int. 2025;36:141-149.
    >> Share

    December 2024
  149. RAMSCHUTZ C, Sollmann N, El Husseini M, Kupfer K, et al
    Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may be a reliable marker for osteoporosis in adults.
    Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07373.
    >> Share

  150. ALHARTHY A
    Assessment of trabecular bone Hounsfield units in the lumbar spine for osteoporosis evaluation in individuals aged 65 and above: a review.
    Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07340.
    >> Share

  151. YUE X, Shi S
    Error in Mendelian randomization analysis in "Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma".
    Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07344.
    >> Share

  152. LIN YC, Chiang PH, Huang JY, Wu WS, et al
    Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users.
    Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07356.
    >> Share

  153. NAGENDRA L, Chandran M, Reginster JY, Bhadada SK, et al
    Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis.
    Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328.
    >> Share

  154. BLAKE RJ, Melemai VK, Fitzpatrick BM, Hubbard DF, et al
    Bilateral femoral neck fractures in pregnancy suggestive of transient osteoporosis of the hip in a patient with hyperparathyroidism: a case report.
    Osteoporos Int. 2024 Dec 24. doi: 10.1007/s00198-024-07346.
    >> Share

  155. YOEL U, Alkobi Weiss H, Goldbart A, Silverman Siris E, et al
    The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study.
    Osteoporos Int. 2024 Dec 18. doi: 10.1007/s00198-024-07325.
    >> Share

  156. CAO D, Chen J, Yu W
    Comment on: Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07306.
    >> Share

  157. ERDEN Y, Temel MH, Bagcier F
    Author response to: OSIN-D-24-00381, artificial intelligence insights into osteoporosis.
    Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07323.
    >> Share

  158. PARK HJ, Kim MG, Yoo YS, Lee B, et al
    Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07335.
    >> Share

  159. SONI M, Shabil M, Sah S
    Comment on "Association of proton-density fat fraction with osteoporosis: a systematic review and meta-analysis".
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07350.
    >> Share

  160. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07332.
    >> Share

  161. VAN OOSTWAARD M, van den Bergh JP, Wyers CE
    Author response to 01530, Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07322.
    >> Share

  162. RAZA MH, Bhutta ME, Siddique MH
    Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07330.
    >> Share

  163. NARLA RR, Adler RA
    Rationale for osteoporosis screening in men.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07337.
    >> Share

  164. KIM CH, Kim K, Kim JW
    The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07314.
    >> Share

  165. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07333.
    >> Share

  166. GU C, Cui Y
    Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07327.
    >> Share

  167. SALMORAL A, Peris P, Lopez Medina C, Florez H, et al
    Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.
    Osteoporos Int. 2024 Dec 3. doi: 10.1007/s00198-024-07309.
    >> Share

  168. PASQUINUCCI E, Limardo M, Salerno FR, Luise CM, et al
    Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports.
    Osteoporos Int. 2024;35:2231-2234.
    >> Share

  169. MARTIN DP 2ND, Lake S, Behun M, Krueger D, et al
    Intraoperative physician assessment during total hip arthroplasty correlates with DXA parameters.
    Osteoporos Int. 2024;35:2145-2151.
    >> Share

  170. TSAI JN, Jordan M, Lee H, Leder BZ, et al
    One versus 2 years of alendronate following denosumab: the CARD extension.
    Osteoporos Int. 2024;35:2225-2230.
    >> Share

  171. RATHMANN W, Kostev K
    Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study.
    Osteoporos Int. 2024;35:2099-2106.
    >> Share

    November 2024
  172. CHEN R, Gong K, Chen W, Chen Z, et al
    Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018.
    Osteoporos Int. 2024 Nov 29. doi: 10.1007/s00198-024-07324.
    >> Share

  173. AZAD TD, Wu RJ, Anderson KE, Darden M, et al
    Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage.
    Osteoporos Int. 2024 Nov 21. doi: 10.1007/s00198-024-07318.
    >> Share

  174. ONTAN MS, Cam Mahser A, Dost FS, Isik AT, et al
    Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.
    Osteoporos Int. 2024 Nov 18. doi: 10.1007/s00198-024-07317.
    >> Share

  175. DE BRUIN IJA, Wyers CE, Vranken L, Schousboe JT, et al
    Systematic evaluation of abdominal aortic calcification in patients with a recent clinical fracture visiting the Fracture Liaison Service.
    Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07288.
    >> Share

  176. DAUNGSUPAWONG H, Wiwanitkit V
    Artificial intelligence insights into osteoporosis: comment.
    Osteoporos Int. 2024 Nov 7. doi: 10.1007/s00198-024-07102.
    >> Share

    October 2024
  177. EVERTS-GRABER J, Reichenbach S, Lehmann T
    Response to the Letter to the Editor regarding "The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland" by Yang and colleagues.
    Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07282.
    >> Share

  178. YANG J, Cao D, Liu A
    Letter to the Editor Regarding "The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland".
    Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07281.
    >> Share

  179. CAO D, Gu N, Liu A
    Comment on: Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Osteoporos Int. 2024 Oct 23. doi: 10.1007/s00198-024-07248.
    >> Share

  180. ADESINA OO, Jenkins IC, Galvao F, de Moura AC, et al
    Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis.
    Osteoporos Int. 2024 Oct 22. doi: 10.1007/s00198-024-07268.
    >> Share

  181. ZHOU K, Li R, Wang J
    Letter to the editor concerning "Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis".
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07287.
    >> Share

  182. HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al
    Letter to editor: rebuttal to OSIN-D-24-01254 "RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07257.
    >> Share

  183. DAUNGSUPAWONG H, Wiwanitkit V
    RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07256.
    >> Share

  184. SHARMA M, Beaudart C, Clark P, Fujiwara S, et al
    Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project.
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07264.
    >> Share

  185. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07284.
    >> Share

  186. CARDINALI DP, Reiter RJ
    Clinical use of melatonin in osteoporosis: Expectations still unmet.
    Osteoporos Int. 2024 Oct 18. doi: 10.1007/s00198-024-07261.
    >> Share

  187. PERSSON R, Hagberg KW, Pranschke E, Vasilakis-Scaramozza C, et al
    Treatment for osteoporosis and risk of osteonecrosis of the jaw among female patients in the United Kingdom Clinical Practice Research Datalink.
    Osteoporos Int. 2024 Oct 14. doi: 10.1007/s00198-024-07262.
    >> Share

  188. DU J, Cui H, Zhao Y, Xue H, et al
    Correction: Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: A mendelian randomization study.
    Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07271.
    >> Share

  189. CHEN H, Lou Y, Fei S, Luo J, et al
    Association between physical activity and mortality in patients with osteoporosis: a cohort study of NHANES.
    Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07280.
    >> Share

  190. BORGSTROM F, Lorentzon M, Johansson H, Harvey NC, et al
    Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK.
    Osteoporos Int. 2024 Oct 4. doi: 10.1007/s00198-024-07251.
    >> Share

  191. AWAN EF, Farooqi HA, Nabi R
    Advancing bone health strategies in Duchenne muscular dystrophy: the role of BMD monitoring in transforming prognosis.
    Osteoporos Int. 2024;35:1865-1866.
    >> Share

  192. DENG X, Wu X, Sun Z, Liu Q, et al
    Associations between new obesity indices and abnormal bone density in type 2 diabetes mellitus patients.
    Osteoporos Int. 2024;35:1807-1815.
    >> Share

    September 2024
  193. TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
    Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2024 Sep 30. doi: 10.1007/s00198-024-07260.
    >> Share

  194. GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
    Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07240.
    >> Share

  195. MASUDA S, Fukasawa T, Matsuda S, Yoshida S, et al
    Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study.
    Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07255.
    >> Share

  196. DU J, Cui H, Zhao Y, Xue H, et al
    Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: a Mendelian randomization study.
    Osteoporos Int. 2024 Sep 23. doi: 10.1007/s00198-024-07249.
    >> Share

  197. CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al
    Correction: Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
    Osteoporos Int. 2024 Sep 18. doi: 10.1007/s00198-024-07245.
    >> Share

  198. ZHAO AS, Liu Y, Mulvey JJ, Tchang BG, et al
    Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report.
    Osteoporos Int. 2024 Sep 17. doi: 10.1007/s00198-024-07243.
    >> Share

  199. GHASEMINEJAD-RAEINI A, Azarboo A, Zareshahi N, Jalali S, et al
    Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Sep 13. doi: 10.1007/s00198-024-07250.
    >> Share

  200. ARMUTCU F, McCloskey E
    Insulin resistance, bone health, and fracture risk.
    Osteoporos Int. 2024 Sep 12. doi: 10.1007/s00198-024-07227.
    >> Share

  201. JAIN RK
    Comment on article "Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms for Fracture Risk".
    Osteoporos Int. 2024 Sep 4. doi: 10.1007/s00198-024-07242.
    >> Share

  202. MAHMUD M, Muscatello DJ, Rahman MB, Osborne NJ, et al
    Association between socioeconomic deprivation and bone health status in the UK biobank cohort participants.
    Osteoporos Int. 2024;35:1573-1584.
    >> Share

    August 2024
  203. LIN CJ, Liu SJ, Lin KY
    Author response to OSIN-D-24-00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07201.
    >> Share

  204. LI J, Zheng J
    Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07200.
    >> Share

  205. HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al
    Clinical features of fallers and non-fallers: finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.
    Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07233.
    >> Share

  206. FAN Z, Zhao J, Chen J, Hu W, et al
    Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study.
    Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07235.
    >> Share

  207. KHADIVI G, Akhtari A, Sharifi F, Zargarian N, et al
    Diagnostic accuracy of artificial intelligence models in detecting osteoporosis using dental images: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 23. doi: 10.1007/s00198-024-07229.
    >> Share

  208. CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al
    Author Response to Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
    Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07192.
    >> Share

  209. TRAN TS, Bliuc D, Blank RD, Center JR, et al
    Fracture risk assessment in the presence of competing risk of death.
    Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07224.
    >> Share

  210. TAO J, Li H, Wang H, Tan J, et al
    Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity.
    Osteoporos Int. 2024 Aug 13. doi: 10.1007/s00198-024-07217.
    >> Share

  211. YUAN K, Liu Q, Luo P, Wang C, et al
    Association of proton-density fat fraction with osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 12. doi: 10.1007/s00198-024-07220.
    >> Share

  212. MCCARROLL K, Fitzpatrick D, Lannon R
    Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07218.
    >> Share

  213. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
    Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07214.
    >> Share

  214. WANG L, Guo X, Qin J, Jin Z, et al
    Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications.
    Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07225.
    >> Share

  215. ZENG Y, Yang Y, Wang J, Meng G, et al
    The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
    Osteoporos Int. 2024 Aug 8. doi: 10.1007/s00198-024-07191.
    >> Share

  216. HADJI P, Kamali L, Thomasius F, Horas K, et al
    Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution peripheral co
    Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07208.
    >> Share

  217. KIRK JM, Rathbun AM, Gruber-Baldini AL, Hochberg MC, et al
    Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.
    Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07211.
    >> Share

  218. HU F, Li X, Zhao D, Chen C, et al
    The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis.
    Osteoporos Int. 2024 Aug 1. doi: 10.1007/s00198-024-07190.
    >> Share

  219. KANIS JA, Dawson-Hughes B, Campusano C, Cooper C, et al
    IOF position on scientists and societies operating in conflict zones.
    Osteoporos Int. 2024;35:1323-1328.
    >> Share

    July 2024
  220. PADERNO A, Gomes EJA, Gilberg L, Maerkisch L, et al
    Correction to: Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review.
    Osteoporos Int. 2024 Jul 31. doi: 10.1007/s00198-024-07206.
    >> Share

  221. TAYLOR L, Matsunaga M, Ahn HJ, Siu AM, et al
    Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawai'i: higher mortality risk among Native Hawaiians and other Pacific Islanders.
    Osteoporos Int. 2024 Jul 30. doi: 10.1007/s00198-024-07195.
    >> Share

  222. REGINSTER JY, Czerwinski E, Wilk K, Borowy P, et al
    Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis.
    Osteoporos Int. 2024 Jul 23. doi: 10.1007/s00198-024-07161.
    >> Share

  223. PATRA S, Boro H, Porchezhian P, Khan N, et al
    Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case-control study from India.
    Osteoporos Int. 2024 Jul 22. doi: 10.1007/s00198-024-07198.
    >> Share

  224. LE HV, Van BW, Shahzad H, Teng P, et al
    Fracture liaison service-a multidisciplinary approach to osteoporosis management.
    Osteoporos Int. 2024 Jul 18. doi: 10.1007/s00198-024-07181.
    >> Share

  225. SCHWARCZ Y, Yanover C, Rouach V, Luria S, et al
    Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures.
    Osteoporos Int. 2024 Jul 13. doi: 10.1007/s00198-024-07169.
    >> Share

  226. PADERNO A, Ataide Gomes EJ, Gilberg L, Maerkisch L, et al
    Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review.
    Osteoporos Int. 2024 Jul 10. doi: 10.1007/s00198-024-07179.
    >> Share

  227. JOHANSSON P, Kristjansdottir HL, Johansson H, Mellstrom D, et al
    Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study.
    Osteoporos Int. 2024 Jul 8. doi: 10.1007/s00198-024-07171.
    >> Share

  228. MOBERG L, Jehpsson L, Nilsson PM, Rosengren B, et al
    Birth weight and birth length affect future fracture risk differently in men and women.
    Osteoporos Int. 2024 Jul 5. doi: 10.1007/s00198-024-07172.
    >> Share

  229. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
    Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
    Osteoporos Int. 2024 Jul 3. doi: 10.1007/s00198-024-07162.
    >> Share

  230. BENSKY MJ, Adler L, Banon T, Gabay L, et al
    Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews.
    Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07174.
    >> Share

  231. PARK SY, Ahn SH, Bae GH, Jang S, et al
    Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07159.
    >> Share

  232. MCCARROLL K, Carroll T, Neville M, Fitzpatrick D, et al
    Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review.
    Osteoporos Int. 2024;35:1299-1302.
    >> Share

    June 2024
  233. PU X, Liu B, Wang D, Xiao W, et al
    Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening.
    Osteoporos Int. 2024 Jun 28. doi: 10.1007/s00198-024-07164.
    >> Share

  234. CORDOVA LA, Gonzalez-Quintanilla D, Heymann D
    Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?
    Osteoporos Int. 2024 Jun 27. doi: 10.1007/s00198-024-07173.
    >> Share

  235. EVERTS-GRABER J, Wenger M, Oser S, Studer U, et al
    The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland.
    Osteoporos Int. 2024 Jun 26. doi: 10.1007/s00198-024-07155.
    >> Share

  236. HOLVIK K, Dahl C, Samuelsen SO, Sogaard AJ, et al
    Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Osteoporos Int. 2024 Jun 25. doi: 10.1007/s00198-024-07133.
    >> Share

  237. BARZILAY JI, Buzkova P, Bielinski SJ, Cotch MF, et al
    The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.
    Osteoporos Int. 2024 Jun 24. doi: 10.1007/s00198-024-07152.
    >> Share

  238. MUZZAMMIL M, Bhura S, Hussain AS, Bashir S, et al
    Undiagnosed vertebral fragility fractures in patients with distal radius fragility fractures: an opportunity for prevention of morbimortality in osteoporotic patients in developing countries.
    Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07149.
    >> Share

  239. SO E, Juels C, Scott RT, Sietsema DL, et al
    A comparison of foot fractures relative to other fragility fractures: a review and analysis of the American Orthopaedic Association's Own the Bone Database.
    Osteoporos Int. 2024 Jun 18. doi: 10.1007/s00198-024-07153.
    >> Share

  240. XU MZ, Lu K, Ye YW, Xu SM, et al
    Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis.
    Osteoporos Int. 2024 Jun 6. doi: 10.1007/s00198-024-07142.
    >> Share

  241. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
    A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07139.
    >> Share

  242. LAROSE G, Al-Azazi S, Lix LM, Bohm E, et al
    Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07131.
    >> Share

  243. TAHMASBI F, Sadoughi F, Sheikhtaheri A, Zabihiyeganeh M, et al
    Developing fracture liaison service framework based on comparative analysis and scoping review.
    Osteoporos Int. 2024 Jun 3. doi: 10.1007/s00198-024-07091.
    >> Share

  244. PLAIS N, Gallego-Bustos J, Mahillo-Fernandez I, Tome-Bermejo F, et al
    Letter to the editor.
    Osteoporos Int. 2024;35:1105-1106.
    >> Share

  245. GUO DM, Weng YZ, Yu ZH, Li SH, et al
    Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation.
    Osteoporos Int. 2024;35:1049-1059.
    >> Share

  246. ZHOU L, Zhou H, Xu H, Sun X, et al
    Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
    Osteoporos Int. 2024;35:997-1005.
    >> Share

    May 2024
  247. DENG L, Shuai P, Liu Y, Yong T, et al
    Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07136.
    >> Share

  248. PARK YB, Kim M, Nam HC, Jeon JW, et al
    Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture.
    Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07138.
    >> Share

  249. KNIGHT KJ, Fordham RJ, Crabtree NJ, Knapp KM, et al
    Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019-2023.
    Osteoporos Int. 2024 May 25. doi: 10.1007/s00198-024-07120.
    >> Share

  250. CHEN Y, Miao Y, Zhang Q
    Association of combined healthy lifestyle factors with incident osteoporosis in patients with and without type 2 diabetes.
    Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07126.
    >> Share

  251. YUE YS, Liu Y, Lu K, Shi Q, et al
    Outdoor walking, genetic predisposition, and the risk of incident osteoporosis among older adults: A prospective large population-based cohort study.
    Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07122.
    >> Share

  252. MORENO-RABIE C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, et al
    Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07108.
    >> Share

  253. WANG X, Zhao X
    Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
    Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07098.
    >> Share

  254. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
    Author Response to OSIN-D-24-00437: Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
    Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07094.
    >> Share

  255. ANSARI H, Jaglal S, Cheung AM, Jain R, et al
    Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada.
    Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07123.
    >> Share

  256. LIN CJ, Lee YS, Yeh JH, Liu SJ, et al
    The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07097.
    >> Share

  257. ALI A, Huszti E, Noordin S, Ali U, et al
    Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 14. doi: 10.1007/s00198-024-07078.
    >> Share

  258. KOBAYASHI T, Morimoto T, Ito K, Mawatari M, et al
    Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials.
    Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07118.
    >> Share

  259. KUSAKABE T, Ishihara Y, Kitamura T, Yasoda A, et al
    Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta.
    Osteoporos Int. 2024 May 8. doi: 10.1007/s00198-024-07089.
    >> Share

  260. XIAO X, Wu Q
    Enhanced fracture risk prediction: a novel multi-trait genetic approach integrating polygenic scores of fracture-related traits.
    Osteoporos Int. 2024 May 7. doi: 10.1007/s00198-024-07105.
    >> Share

  261. LIU B, Ng CY, La PBD, Wong P, et al
    Osteoporosis and fracture risk assessment in adults with ischaemic stroke.
    Osteoporos Int. 2024 May 4. doi: 10.1007/s00198-024-07099.
    >> Share

    April 2024
  262. PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al
    Refracture and mortality risk in the elderly with osteoporotic fractures: the AGES-Reykjavik study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096.
    >> Share

  263. GOLD DT, Beckett T, Deal C, James AL, et al
    Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070.
    >> Share

  264. WANG M, Seibel MJ
    Secondary fracture prevention in primary care: a narrative review.
    Osteoporos Int. 2024 Apr 23. doi: 10.1007/s00198-024-07036.
    >> Share

  265. ZUBICK P, Dahlke S
    Family/caregiver influence on osteoporosis management for older people: an integrative review.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081.
    >> Share

  266. AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al
    The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085.
    >> Share

  267. WU J, Li J, Yan Z, Yu X, et al
    Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010.
    Osteoporos Int. 2024 Apr 12. doi: 10.1007/s00198-024-07083.
    >> Share

  268. CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al
    Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
    Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059.
    >> Share

  269. LANE J, Langdahl B, Stone M, Kurth A, et al
    Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
    Osteoporos Int. 2024 Apr 4. doi: 10.1007/s00198-024-07049.
    >> Share

  270. GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043.
    >> Share

  271. ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al
    The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075.
    >> Share

  272. FUJITA N, Ono Y, Hashimoto K, Kawamura Y, et al
    Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report.
    Osteoporos Int. 2024;35:733-736.
    >> Share

  273. WHITING PS, Hare K, Krueger D, Borchardt G, et al
    Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis.
    Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057.
    >> Share

    March 2024
  274. KOBAYASHI T, Morimoto T, Mawatari M
    Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures.
    Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063.
    >> Share

  275. CAI Y, Jun G, Zhuang X
    Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
    Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013.
    >> Share

  276. DANAZUMI MS, Lightbody N, Dermody G
    Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-024-07052.
    >> Share

  277. LORENTZON M, Litsne H, Axelsson KF
    The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
    Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072.
    >> Share

  278. LI D, Mao SS, Budoff MJ
    Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
    Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040.
    >> Share

  279. PARK HJ, Kim MG, Yoo YS, Lee B, et al
    Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-analysis.
    Osteoporos Int. 2024 Mar 21. doi: 10.1007/s00198-024-07065.
    >> Share

  280. PLUSKIEWICZ W, Tabor E
    The comments on manuscript entitled 'Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study'.
    Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056.
    >> Share

  281. DAS L, Laway BA, Sahoo J, Dhiman V, et al
    Bone mineral density, turnover, and microarchitecture assessed by second-generation high-resolution peripheral quantitative computed tomography in patients with Sheehan's syndrome.
    Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07062.
    >> Share

  282. MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al
    The yield of routine laboratory examination in osteoporosis evaluation in primary care.
    Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042.
    >> Share

  283. TAGUCHI A
    Letters to the Editor for "Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study".
    Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058.
    >> Share

  284. PARK HJ, Kim MG, Yoo YS, Lee BR, et al
    Determination of the Combined Effects of Asian Herbal Medicine with Calcium and/or Vitamin D Supplements on Bone Mineral Density in Primary Osteoporosis: A Systematic Review and Meta-Analysis.
    Osteoporos Int. 2024 Mar 13. doi: 10.1007/s00198-024-07061.
    >> Share

  285. CRANDALL CJ, Larson J, Shadyab AH, LeBoff MS, et al
    Physical function trajectory after wrist or lower arm fracture in postmenopausal women: results from the Women's Health Initiative Study.
    Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07050.
    >> Share

  286. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
    Associations between ultra-distal forearm bone mineral density and incident fracture in women.
    Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041.
    >> Share

  287. CHEN L, Li C, Chen H, Xie Y, et al
    Cross-sectional studies of the causal link between asthma and osteoporosis: insights from Mendelian randomization and bioinformatics analysis.
    Osteoporos Int. 2024 Mar 2. doi: 10.1007/s00198-024-07037.
    >> Share

    February 2024
  288. BLAY R, Flores LE, Kupzyk K, Waltman N, et al
    Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.
    Osteoporos Int. 2024 Feb 17. doi: 10.1007/s00198-023-07008.
    >> Share

  289. PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al
    CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029.
    >> Share

  290. ZHANG H, Yang F, Cao Z, Xu Y, et al
    The influence of iron on bone metabolism disorders.
    Osteoporos Int. 2024;35:243-253.
    >> Share

  291. YANG Q, He J, Yuan F
    Improvement of proportion of days covered for denosumab under implementation of clinical pharmacist adherence management system: normal and COVID-19 period.
    Osteoporos Int. 2024;35:309-316.
    >> Share

  292. RAMCHAND SK, Tsai JN, Lee H, Sassana-Khadka G, et al
    The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
    Osteoporos Int. 2024;35:255-263.
    >> Share

    January 2024
  293. EBINA K, Nagayama Y, Kashii M, Tsuboi H, et al
    An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case-control study.
    Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07019.
    >> Share

  294. YU W, Guan WM, Hayashi D, Lin Q, et al
    Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique.
    Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024.
    >> Share

  295. CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al
    Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service.
    Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033.
    >> Share

  296. BENNETT MJ, Center JR, Perry L
    Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014.
    >> Share

  297. SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al
    Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026.
    >> Share

  298. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwi
    Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023.
    >> Share

  299. JEON S, Yu D, Kim S, Kim SW, et al
    Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
    Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025.
    >> Share

  300. CAO X, Keyak JH, Sigurdsson S, Zhao C, et al
    A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure.
    Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015.
    >> Share

  301. BYUN SE, Kim H, Lee SY, Kim SM, et al
    Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.
    Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022.
    >> Share

  302. SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al
    Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study.
    Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017.
    >> Share

  303. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
    Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012.
    >> Share

  304. ZENG L, Li Y, Hong C, Wang J, et al
    Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
    Osteoporos Int. 2024 Jan 15. doi: 10.1007/s00198-023-06996.
    >> Share

  305. LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
    Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
    Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974.
    >> Share

  306. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al
    Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.
    Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005.
    >> Share

  307. MULKERRIN P, O'Shea F, Fitzgerald G
    Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010.
    >> Share

    December 2023
  308. MCCARROLL K, Fitzpatrick D, McCormack M, Abdelfadil S, et al
    Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review.
    Osteoporos Int. 2023 Dec 28. doi: 10.1007/s00198-023-07006.
    >> Share

  309. CHEN H, Zhu X, Zhou Q, Pu X, et al
    Utility of MRI-based vertebral bone quality scores and CT-based Hounsfield unit values in vertebral bone mineral density assessment for patients with diffuse idiopathic skeletal hyperostosis.
    Osteoporos Int. 2023 Dec 27. doi: 10.1007/s00198-023-06999.
    >> Share

  310. MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al
    Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.
    Osteoporos Int. 2023 Dec 26. doi: 10.1007/s00198-023-07000.
    >> Share

  311. DING W, Huang Y, Li G, Dong Y, et al
    Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence.
    Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-07004.
    >> Share

  312. MAGNO LAV, Tameirao DR, Alves LF, Guimaraes NS, et al
    Effect of recreational cannabis use on bone mineral density: a systematic review.
    Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-06992.
    >> Share

  313. CHAVASSIEUX P, Roux JP, Chapurlat R
    Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level.
    Osteoporos Int. 2023 Dec 22. doi: 10.1007/s00198-023-06972.
    >> Share

  314. YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al
    Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture.
    Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976.
    >> Share

  315. YOO JE, Huh Y, Kim E, Park SH, et al
    Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study.
    Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983.
    >> Share

  316. GUIMARAES GC, Coelho JBC, Silva JGO, de Sant'Ana ACC, et al
    Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health.
    Osteoporos Int. 2023 Dec 6. doi: 10.1007/s00198-023-06991.
    >> Share

  317. HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
    Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
    Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975.
    >> Share

    November 2023
  318. NIZNIK JD, Kelley CJ, Fasth L, Colon-Emeric C, et al
    Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers.
    Osteoporos Int. 2023 Nov 18. doi: 10.1007/s00198-023-06967.
    >> Share

  319. BEAUDART C, Sharma M, Clark P, Fujiwara S, et al
    Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
    Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955.
    >> Share

  320. CHEN KH, Su CM, Liu WJ, Tzeng HE, et al
    The joint effects of physical activity and sleep duration on risk of osteoporosis in Taiwanese adult population: The Taiwan Biobank Study.
    Osteoporos Int. 2023 Nov 10. doi: 10.1007/s00198-023-06947.
    >> Share

  321. KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al
    Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures.
    Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965.
    >> Share

  322. NAJAFI S, Mohammadkhah F, Ebrahimi MM, Harsini PA, et al
    Effect of educational intervention on preventing osteoporosis in postmenopausal women.
    Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06962.
    >> Share

  323. AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al
    The incremental risk of fragility fractures in aging men.
    Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956.
    >> Share

  324. CHEN Q, Tu Z, Ai Y, Li W, et al
    Forearm bone mineral density predicts screw loosening after lumbar fusion similar to lumbar Hounsfield unit value in patients with lumbar spondylolisthesis.
    Osteoporos Int. 2023 Nov 3. doi: 10.1007/s00198-023-06957.
    >> Share

    October 2023
  325. HAN S, Kim S, Yeh EJ, Suh HS, et al
    Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934.
    >> Share

  326. INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al
    Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944.
    >> Share

  327. HEUCHERT J, Koziel S, Spinek AE
    Radiomorphometric indices of the mandible as indicators of decreased bone mineral density and osteoporosis - meta-analysis and systematic review.
    Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06949.
    >> Share

  328. LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al
    Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
    Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951.
    >> Share

  329. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927.
    >> Share

  330. KOVACS CS
    Fraudulent, duplicate publication of pregnancy/lactation data in Osteoporosis International.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06939.
    >> Share

  331. ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al
    Association between total and animal proteins with risk of fracture: A systematic review and dose-response meta-analysis of cohort studies.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948.
    >> Share

  332. PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al
    Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment.
    Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936.
    >> Share

  333. GROVLE L, Haugen AJ, Johansen M, Hasvik E, et al
    The terminologies of transient, migratory, or localized osteoporosis, and bone marrow edema syndrome: a scoping review.
    Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06929.
    >> Share

  334. YAN F, Wu L, Lang J, Huang Z, et al
    Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925.
    >> Share

  335. LI N, van den Bergh JP, Boonen A, Wyers CE, et al
    Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
    Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924.
    >> Share

  336. MAKRAS P, Yavropoulou MP, Polyzos SA, Papapoulos SE, et al
    The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.
    Osteoporos Int. 2023 Oct 2. doi: 10.1007/s00198-023-06931.
    >> Share

  337. OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al
    Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
    Osteoporos Int. 2023;34:1799-1804.
    >> Share

  338. BAGHERIFARD A, Hosseinzadeh A, Koosha F, Sheibani M, et al
    Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.
    Osteoporos Int. 2023;34:1677-1701.
    >> Share

    September 2023
  339. MAAS L, Raskin N, van Onna M, Cornelissen D, et al
    Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
    Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906.
    >> Share

  340. SOLOMON DH, Ruppert K, Cauley JA, Lian Y, et al
    The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women's Health Across the Nation (SWAN).
    Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06915.
    >> Share

  341. HUNG WC, Lin YL, Cheng TT, Chin WL, et al
    Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
    Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913.
    >> Share

  342. FUJISHIMA R, Ushimaru S, Sumi H, Aso M, et al
    Effect of denosumab on bone mineral density in a postmenopausal osteoporotic woman with prolonged chronic mild hyponatremia.
    Osteoporos Int. 2023 Sep 19. doi: 10.1007/s00198-023-06898.
    >> Share

  343. LIU X, Makaroff KE, Almario CV, Khalil C, et al
    Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882.
    >> Share

  344. ELWAKIL W, El Gaafary M, El Miedany Y
    Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914.
    >> Share

  345. CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al
    Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
    Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894.
    >> Share

  346. LEE RH, Curtis J, Drake MT, Bobo Tanner S 4th, et al
    Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients.
    Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06912.
    >> Share

  347. LU K, Wu YM, Shi Q, Gong YQ, et al
    A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905.
    >> Share

  348. NICOLAES J, Liu Y, Zhao Y, Huang P, et al
    External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans.
    Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903.
    >> Share

  349. PENG T, Zeng X, Li Y, Li M, et al
    A study on whether deep learning models based on CT images for bone density classification and prediction can be used for opportunistic osteoporosis screening.
    Osteoporos Int. 2023 Sep 5. doi: 10.1007/s00198-023-06900.
    >> Share

  350. LIU J, Tang Y, Peng B, Tian C, et al
    Bone mineral density is associated with composite dietary antioxidant index among US adults: results from NHANES.
    Osteoporos Int. 2023 Sep 4. doi: 10.1007/s00198-023-06901.
    >> Share

  351. KARPUZ S
    Zoledronic acid-induced severe lymphopenia.
    Osteoporos Int. 2023;34:1653-1655.
    >> Share

    August 2023
  352. MOAYYERI A, Warden J, Han S, Suh HS, et al
    Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
    Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895.
    >> Share

  353. WANG J, Xing F, Sheng N, Xiang Z, et al
    Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey.
    Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06896.
    >> Share

  354. SHAHROUR E
    A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy).
    Osteoporos Int. 2023 Aug 30. doi: 10.1007/s00198-023-06876.
    >> Share

  355. BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al
    Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
    Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890.
    >> Share

  356. BARCELOS A, Goncalves J, Mateus C, Canhao H, et al
    Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881.
    >> Share

  357. HONG N, Shin S, Lee S, Rhee Y, et al
    Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889.
    >> Share

  358. ABDALBARY M, El-Husseini A
    Author response to: Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06874.
    >> Share

  359. TURABI RY, Sheehan KJ
    Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864.
    >> Share

  360. MARTINS MJ
    Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763-774.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06873.
    >> Share

  361. MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al
    The importance of structural barriers of osteoporotic hip fracture in the elderly.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875.
    >> Share

  362. LI W, Zhao H, Zhou S, Xiong Z, et al
    Does vertebral osteoporosis delay or accelerate lumbar disc degeneration? A systematic review.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06880.
    >> Share

  363. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
    Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870.
    >> Share

  364. SEO DH, Jeong Y, Cho Y, Kim SH, et al
    Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
    Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879.
    >> Share

  365. FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al
    Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naive patients: two further cases.
    Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869.
    >> Share

    July 2023
  366. HE D, Liu H, Wei W, Zhao Y, et al
    A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank.
    Osteoporos Int. 2023 Jul 27. doi: 10.1007/s00198-023-06852.
    >> Share

  367. THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al
    A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857.
    >> Share

  368. EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863.
    >> Share

  369. MAZEDA C, Barcelos A
    Gender differences in osteoporosis.
    Osteoporos Int. 2023 Jul 20. doi: 10.1007/s00198-023-06858.
    >> Share

  370. TAN EH, Robinson DE, Jodicke AM, Mosseveld M, et al
    Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
    Osteoporos Int. 2023 Jul 12. doi: 10.1007/s00198-023-06837.
    >> Share

  371. SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al
    Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
    Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829.
    >> Share

  372. HASEGAWA T
    Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wo
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06835.
    >> Share

  373. SOMAY E
    Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06821.
    >> Share

  374. JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al
    The Capture the Fracture(R) Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit.
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759.
    >> Share

  375. SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al
    Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Dis
    Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817.
    >> Share

    June 2023
  376. SCHOUSBOE JT, Binkley N, Leslie WD
    Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
    Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820.
    >> Share

  377. MOON RJ, Reginster JY, Al-Daghri NM, Thiyagarajan JA, et al
    Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Osteoporos Int. 2023 Jun 23. doi: 10.1007/s00198-023-06827.
    >> Share

  378. KADRI A, Binkley N, Hernando D, Anderson PA, et al
    Author response to letter to editor: OSIN-D-23-00474, "letter to the editor regarding 'Opportunistic use of lumbar magnetic resonance imaging for osteoporosis screening'".
    Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06808.
    >> Share

  379. PU X, Li H
    Letter to the editor regarding "Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening".
    Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06801.
    >> Share

  380. LIU FC, Luk KC, Chen YC
    Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
    Osteoporos Int. 2023 Jun 16. doi: 10.1007/s00198-023-06818.
    >> Share

  381. HUANG G, Chen X, Chen Y, Liu W, et al
    Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population.
    Osteoporos Int. 2023 Jun 12. doi: 10.1007/s00198-023-06807.
    >> Share

  382. PASKINS Z, Moult A, Corp N, Bastounis A, et al
    Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
    Osteoporos Int. 2023 Jun 9. doi: 10.1007/s00198-023-06806.
    >> Share

  383. HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al
    Osteoporosis medication adherence tools: a systematic review.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789.
    >> Share

  384. HAGINO H, Moriwaki K, Wada T, Osaki M, et al
    Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816.
    >> Share

  385. KUNIHARA T, Tohmori H, Tsukamoto M, Kobayashi M, et al
    Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
    Osteoporos Int. 2023;34:1101-1109.
    >> Share

    May 2023
  386. LIN SM, Lin JY, Tu YK, Wu CH, et al
    Association between bisphosphonate use and stroke risk: a meta-analysis.
    Osteoporos Int. 2023 May 30. doi: 10.1007/s00198-023-06781.
    >> Share

  387. LU K, Wu YM, Shi Q, Gong YQ, et al
    The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803.
    >> Share

  388. GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al
    Mortality among older adults with osteoporotic vertebral fracture.
    Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796.
    >> Share

  389. ZHU K, Hunter M, James A, Lim EM, et al
    Relationships between longitudinal changes in body composition and bone mineral density in middle-to-older aged Australians.
    Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06773.
    >> Share

  390. LAI SW
    Adipopenia associated with osteoporosis.
    Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06797.
    >> Share

  391. KWON H, Han KD, Kim BS, Moon SJ, et al
    Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study.
    Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800.
    >> Share

  392. RASHIDI MM, Saeedi Moghaddam S, Azadnajafabad S, Heidari-Foroozan M, et al
    Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990-2019.
    Osteoporos Int. 2023 May 23. doi: 10.1007/s00198-023-06778.
    >> Share

  393. KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al
    Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793.
    >> Share

  394. YANG H, Bai J, Li L, Yang Y, et al
    Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785.
    >> Share

  395. AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al
    The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty.
    Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746.
    >> Share

  396. AVGERINOU C, Petersen I, Clegg A, West RM, et al
    Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data.
    Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739.
    >> Share

  397. METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al
    Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
    Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728.
    >> Share

    April 2023
  398. HO-PHAM LT, Nguyen HG, Nguyen-Pham SQ, Hoang DK, et al
    Longitudinal changes in bone mineral density during perimenopausal transition: the Vietnam Osteoporosis Study.
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06757.
    >> Share

  399. RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al
    Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752.
    >> Share

  400. MOON RJ, Green HD, D'Angelo S, Godfrey KM, et al
    The effect of pregnancy vitamin D supplementation on offspring bone mineral density in childhood: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06751.
    >> Share

  401. BENNETT MJ, Center JR, Perry L
    Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.
    Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748.
    >> Share

  402. HILL EC, O'Donnell L
    Low bone mineral density is associated with fatty liver disease and respiratory illness in a pediatric mortality sample.
    Osteoporos Int. 2023 Apr 21. doi: 10.1007/s00198-023-06760.
    >> Share

  403. CHANG CM, Chen YC, Wu WT, Lin TK, et al
    Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study.
    Osteoporos Int. 2023 Apr 20. doi: 10.1007/s00198-023-06756.
    >> Share

  404. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
    Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday rea
    Osteoporos Int. 2023 Apr 13. doi: 10.1007/s00198-023-06745.
    >> Share

  405. PONZANO M, Tibert N, Brien S, Funnell L, et al
    Publisher Correction: International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
    Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717.
    >> Share

  406. ICONARU L, Charles A, Baleanu F, Moreau M, et al
    Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
    Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737.
    >> Share

  407. KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al
    Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
    Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640.
    >> Share

  408. TANG Y, Zhang L, Ye D, Zhao A, et al
    Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.
    Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734.
    >> Share

  409. MATTICK LJ, Bea JW, Hovey KM, Wactawski-Wende J, et al
    Follicle-stimulating hormone is associated with low bone mass in postmenopausal women.
    Osteoporos Int. 2023;34:693-701.
    >> Share

    March 2023
  410. LEGRAND A, Autrusseau F, Bandiaky ON, Idiri K, et al
    Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06724.
    >> Share

  411. NICKEL B, Krueger D, Borchardt G, Andersen L, et al
    Intraoperative physician assessment of bone: correlation to bone mineral density.
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06729.
    >> Share

  412. GOEL H, Binkley N, Hans D, Leslie WD, et al
    Bone density and trabecular bone score to predict fractures in adults aged 20-39 years: a registry-based study.
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722.
    >> Share

  413. LIN Z, Shi G, Liao X, Liu W, et al
    Effect of pulmonary function on bone mineral density in the United States: results from the NHANES 2007-2010 study.
    Osteoporos Int. 2023 Mar 23. doi: 10.1007/s00198-023-06727.
    >> Share

  414. BINKLEY N, Nickel B, Anderson PA
    Periprosthetic fractures: an unrecognized osteoporosis crisis.
    Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695.
    >> Share

  415. BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al
    Epidemiology of male osteoporosis in Denmark (1996-2018).
    Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720.
    >> Share

  416. EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al
    Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
    Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627.
    >> Share

  417. HANS D, McDermott M, Huang S, Kim M, et al
    Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708.
    >> Share

  418. TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al
    Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693.
    >> Share

  419. HU J, Li Y, Wang Z, Li X, et al
    Association of plant-based dietary patterns with the risk of osteoporosis in community-dwelling adults over 60 years: a cross-sectional study.
    Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06700.
    >> Share

    February 2023
  420. JUNG SY, Cho EB, Han KD, Jung JH, et al
    Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715.
    >> Share

  421. HE D, Pan C, Zhao Y, Wei W, et al
    Exome-wide screening identifies novel rare risk variants for bone mineral density.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710.
    >> Share

  422. XIAO X, Wu Q
    Ethnic disparities in fracture risk assessment using polygenic scores.
    Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712.
    >> Share

  423. YE C, Lee K, Leslie WD, Lin M, et al
    Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.
    Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06690.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016